Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | TRPC5 | Q9UL62 | 1/20 | 0.32 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 3/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16425569 | 0.83 | OPRM1 (0.42) | HCAR1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL15856642 | 0.83 | ALDH1A1 (0.45) | MGLLALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL15352370 | 0.81 | ELANE (0.33) | MGLL | |
| SCHEMBL18546250 | 0.81 | GABRA1 (0.47) | HCAR1MGLLTRPC5TSHRMEN1 | |
| SCHEMBL17986274 | 0.81 | ELANE (0.33) | MGLL | |
| SCHEMBL15352598 | 0.81 | JAK2 (0.43) | HCAR1MGLLPDE7ANFE2L2GSK3A | |
| SCHEMBL18037172 | 0.81 | ALDH1A1 (0.41) | MGLLALDH1A1TSHRKMT2AGSK3B | |
| SCHEMBL18504502 | 0.81 | ALDH1A1 (0.34) | MGLLALDH1A1TSHRNFE2L2MEN1 | |
| SCHEMBL31398191 | 0.79 | — | — | |
| SCHEMBL19994311 | 0.78 | NFE2L2 (0.35) | MGLLALDH1A1TSHRNFE2L2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108409678-B | Process for producing tetrazolinone compound | 住友化学株式会社 | 2021-04-27 | — | — | CN | disclosed |
| US-9822085-B2 | Method for producing tetrazolinone compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-21 | — | — | US | disclosed |
| US-9822085-B2 | Method for producing tetrazolinone compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-21 | — | — | US | disclosed |
| US-9822085-B2 | Method for producing tetrazolinone compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20170057935-A1 | METHOD FOR PRODUCING TETRAZOLINONE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20170057935-A1 | METHOD FOR PRODUCING TETRAZOLINONE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20170057935-A1 | METHOD FOR PRODUCING TETRAZOLINONE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170057935-A1 | METHOD FOR PRODUCING TETRAZOLINONE COMPOUND | CYP2F1, F12, XDH | HCAR1 2143/4885MGLL 2721/4885TRPC5 4273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.